Cargando…
Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy
Diffuse large B cell lymphoma (DLBCL) comprises specific subtypes, disease entities, and other not otherwise specified (NOS) lymphomas. This review will focus on DLBCL NOS because of their prevalence and their heterogeneity with respect to morphology, clinical presentation, biology, and response to...
Autores principales: | Carbone, Antonino, Gloghini, Annunziata, Kwong, Yok-Lam, Younes, Anas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082139/ https://www.ncbi.nlm.nih.gov/pubmed/24870942 http://dx.doi.org/10.1007/s00277-014-2116-y |
Ejemplares similares
-
Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015) -
Epstein Barr Virus-Associated Hodgkin Lymphoma
por: Carbone, Antonino, et al.
Publicado: (2018) -
Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma
por: Carbone, Antonino, et al.
Publicado: (2023) -
Extracavitary KSHV-positive Solid Lymphoma: A Large B-cell Lymphoma Within the Spectrum of Primary Effusion Lymphoma
por: Carbone, Antonino, et al.
Publicado: (2013) -
Optimizing checkpoint inhibitors therapy for relapsed or progressive classic Hodgkin lymphoma by multiplex immunohistochemistry of the tumor microenvironment
por: Carbone, Antonino, et al.
Publicado: (2019)